Soleno Therapeutics Balance Sheet (2013-2026) | SLNO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	33.60M	28.18M	21.30M	29.00M	24.07M	19.75M	14.60M	7.90M	19.37M	52.40M	169.68M	42.80M	57.02M	48.40M	87.93M	81.33M	76.50M	246.66M	70.11M	133.03M
Short-term Investments (Quarter)												106.80M	209.10M	208.36M	203.51M	208.60M	210.34M	252.27M	235.37M	122.57M
Cash & Current Investments (Quarter)	33.60M	28.18M	21.30M	29.00M	24.07M	19.75M	14.60M	7.90M	19.37M	52.40M	169.68M	149.60M	266.12M	256.76M	291.44M	289.93M	286.84M	498.93M	305.47M	255.60M
Receivables - Net (Quarter)																	24.62M	25.51M	28.21M	47.14M
Receivables - Other (Quarter)
Receivables (Quarter)																	24.62M	25.51M	28.21M	47.14M
Raw Materials (Quarter)																	1.14M	4.17M	6.45M	4.77M
Work In Process (Quarter)																	0.95M	2.02M	2.71M	5.57M
Finished Goods (Quarter)																	0.26M	0.53M	6.02M	7.22M
Inventory (Quarter)																	2.35M	6.67M	15.02M	17.31M
Prepaid Assets (Quarter)	0.95M	0.70M	1.12M	1.00M	0.82M	0.82M	1.04M	1.25M	1.13M	1.22M	1.68M	1.60M	1.38M	1.42M	2.45M	18.96M	2.97M	3.74M	7.11M	6.33M
Current Assets (Quarter)	34.54M	28.89M	22.42M	29.98M	24.89M	20.57M	15.65M	9.13M	20.50M	53.66M	171.36M	151.22M	267.50M	258.20M	293.89M	308.92M	316.79M	534.85M	355.81M	326.38M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.03M	0.03M	0.03M	0.03M	0.03M	0.02M	0.03M	0.02M	0.02M	0.01M	0.01M	0.03M	0.02M	0.20M	0.19M	0.17M	0.17M	0.15M	0.18M	0.20M
Long-Term Investments (Quarter)												8.80M	28.50M	27.90M	27.21M		7.00M	57.15M	200.62M	273.38M
Goodwill (Quarter)
Intangibles (Quarter)	13.61M	13.12M	12.64M	12.15M	11.66M	11.18M	10.69M	10.21M	9.72M	9.23M	8.75M	8.26M	7.78M	7.29M	6.80M	6.32M	5.83M	5.35M	4.86M	4.37M
Goodwill & Intangibles (Quarter)	13.61M	13.12M	12.64M	12.15M	11.66M	11.18M	10.69M	10.21M	9.72M	9.23M	8.75M	8.26M	7.78M	7.29M	6.80M	6.32M	5.83M	5.35M	4.86M	4.37M
Other Non-Current Assets (Quarter)	0.04M	0.04M	0.04M	0.04M				0.13M	0.17M	0.17M	0.17M	0.17M	0.08M	0.08M	0.08M	0.08M	0.08M	0.08M	0.16M	0.16M
Non-Current Assets (Quarter)	14.23M	13.68M	13.13M	12.57M	11.97M	11.41M	10.85M	10.41M	10.45M	9.89M	9.33M	17.61M	36.63M	38.51M	37.08M	9.18M	15.52M	65.04M	208.02M	282.01M
Assets (Quarter)	48.78M	42.56M	35.55M	42.55M	36.86M	31.98M	26.50M	19.54M	30.94M	63.55M	180.69M	168.84M	304.13M	296.71M	330.97M	318.09M	332.31M	599.89M	563.83M	608.39M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.35M	3.86M	3.25M	2.41M	2.41M	2.32M	1.78M	2.78M	3.44M	3.22M	3.15M	8.02M	3.72M	6.24M	8.88M	5.48M	6.22M	8.14M	12.44M	12.39M
Payables (Quarter)	3.35M	3.86M	3.25M	2.41M	2.41M	2.32M	1.78M	2.78M	3.44M	3.22M	3.15M	8.02M	3.72M	6.24M	8.88M	5.48M	6.22M	8.14M	12.44M	12.39M
Accumulated Expenses (Quarter)	0.65M	0.81M	0.73M	0.60M	0.93M	1.28M	1.68M	0.72M	1.17M	1.50M	3.13M	1.23M	2.15M	3.41M	4.78M	4.28M	0.41M	7.25M	9.68M	5.72M
Other Accumulated Expenses (Quarter)	0.26M	0.49M	0.32M	0.44M	0.41M	0.67M	0.48M	0.69M	0.51M	0.85M	1.55M	1.51M	1.13M	3.10M	4.56M	3.13M	5.51M	17.16M	18.20M	24.93M
Short term Debt (Quarter)
Current Leases (Quarter)	0.18M	0.30M	0.30M	0.30M	0.30M	0.24M	0.20M	0.04M	0.21M	0.26M	0.30M	0.30M	0.30M	0.45M	0.50M	0.60M	0.68M	0.70M	0.73M	1.16M
Current Taxes (Quarter)																				2.77M
Total Current Liabilities (Quarter)	8.36M	9.04M	8.01M	7.31M	7.25M	7.34M	7.31M	7.76M	8.80M	28.99M	11.51M	13.46M	9.15M	14.96M	18.75M	15.73M	20.94M	33.25M	61.36M	58.05M
Non-Current Liabilities
Non-Current Debt (Quarter)															49.83M	49.84M	49.84M	49.85M	49.86M	49.87M
Convertible Debt (Quarter)
Preferred Stock Liabilities (Quarter)
Liabilities from Discontinued Operations (Quarter)
Non-Current Deferred Tax Liability (Quarter)											1.92M
Operating Leases (Quarter)	0.50M	0.27M	0.17M	0.08M					0.27M	0.21M	0.10M	0.04M		2.58M	2.47M	2.36M	2.20M	2.11M	1.96M	3.20M
Other Non-Current Liabilities (Quarter)	12.32M	12.88M	9.55M	8.69M	9.30M	9.44M	8.84M	9.13M	9.45M	10.47M	11.55M	11.95M	13.59M	14.46M	14.79M	17.76M	0.27M	19.47M	0.53M	1.43M
Total Non-Current Liabilities (Quarter)	9.02M	9.49M	8.21M	7.40M	7.25M	7.34M	7.31M	7.76M	9.07M	29.86M	11.63M	13.50M	9.79M	17.54M	71.07M	68.07M	91.89M	85.62M	113.19M	111.16M
Total Liabilities (Quarter)	21.34M	22.36M	17.76M	16.09M	16.55M	16.78M	16.15M	16.90M	18.52M	40.33M	23.18M	25.45M	23.37M	32.01M	85.86M	85.83M	92.17M	105.09M	113.72M	112.59M
Shareholder's Equity
Total Debt (Quarter)															49.83M	49.84M	49.84M	49.85M	49.86M	49.87M
Common Equity (Quarter)	27.44M	20.20M	17.79M	26.46M	20.31M	15.20M	10.35M	2.64M	12.43M	23.22M	157.51M	143.39M	280.76M	264.70M	245.11M	232.26M	240.14M	494.81M	450.12M	495.80M
Shareholder's Equity (Quarter)	27.44M	20.20M	17.79M	26.46M	20.31M	15.20M	10.35M	2.64M	12.43M	23.22M	157.51M	143.39M	280.76M	264.70M	245.11M	232.26M	240.14M	494.81M	450.12M	495.80M
Liabilities and Shareholders Equity (Quarter)	48.78M	42.56M	35.55M	42.55M	36.86M	31.98M	26.50M	19.54M	30.94M	63.55M	180.69M	168.84M	304.13M	296.71M	330.97M	318.09M	332.31M	599.89M	563.83M	608.39M
Retained Earnings (Quarter)	-202.39M	-210.53M	-213.35M	-219.08M	-225.80M	-0.00M	-237.42M	-245.80M	-254.25M	-265.10M	-276.41M	-0.11M	-319.70M	-396.30M	-452.26M	-496.00M	-500.74M	0.36M	0.41M	-400.00M
Treasury Shares (Quarter)	0.44M	0.44M	0.03M	0.29M	0.29M	0.02M	0.02M	0.01M	0.42M	0.42M	0.02M	0.30M	0.26M	1.07M	0.94M	0.36M	0.47M	0.47M	0.44M	1.16M

Research Tools

Developers

Soleno Therapeutics Balance Sheet (2013-2026) | SLNO

Research Tools

Developers

Soleno Therapeutics Balance Sheet (2013-2026) | SLNO

Create an account

Sign In

Reset Password